, ,
NanoMedical Systems

The Benefits Of Ozempic Without The Shot

About this Event

One of the biggest challenges for patients with chronic conditions like diabetes, addiction disorder, and pain, is making sure to take their medication regularly.

NanoMedical Systems has solved that challenge with nStrada, a refillable, sustained release drug delivery platform that is implanted under the skin and can last for a year or more. The system uses diffusion-based kinetics to ensure precise dosaging and nStrada can be used with a variety of medications for a variety of conditions.

The company’s first program is targeting Type 2 Diabetes using the drug Exenatide, providing all the benefits of Wegovy and Ozempic without the shot. Now patients will never forget their medication and always get the proper dose without spikes or dips.

Watch our webinar with NanoMedical CEO, Michael Matula to hear how their nStrada drug delivery platform has the potential to transform treatment for type 2 diabetes, weight loss, opioid use disorder, chronic pain, and more. 

Hosted by Steven Saltzstein, CEO, Force Family Office

Video On Demand

– Recorded

June 25

SHARE THIS EVENT

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.